INTS

Intensity Therapeutics, Inc.

5.05 USD
+0.14 (+2.85%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Intensity Therapeutics, Inc. stock is up 23.77% since 30 days ago. The next earnings date is Aug 12, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 100% of the previous 1 May’s closed higher than April. 100% of analysts rate it a buy.

About Intensity Therapeutics, Inc.

Intensity Therapeutics, Inc. is a clinical stage biotechnology company passionately committed to applying scientific leadership in the field of localized cancer reduction leading to anti-cancer immune activation. Our new approach involves the direct injection into tumors of a unique product created from our DfuseRx℠ discovery platform. Our principal executive offices are located at 61 Wilton Road, 3rd Floor, Westport, CT.